IS7012A - Adenosine A2A receptor agonist and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease - Google Patents

Adenosine A2A receptor agonist and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease

Info

Publication number: IS7012A
Authority: IS; Iceland
Prior art keywords: cocaine; obstructive; adenosine; disease; mixture
Prior art date: 2001-05-25

Application number

IS7012A

Other languages

Icelandic (is)

Inventor

A. Armstrong Roisin

Yeadon Michael

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-25

Filing date

2003-10-31

Publication date

2003-10-31

2001-12-06 Priority claimed from GB0129275A external-priority patent/GB0129275D0/en

2001-12-07 Priority claimed from GB0129396A external-priority patent/GB0129396D0/en

2002-05-03 Priority claimed from GB0210240A external-priority patent/GB0210240D0/en

2002-05-03 Priority claimed from GB0210238A external-priority patent/GB0210238D0/en

2002-05-24 Priority claimed from PCT/EP2002/005725 external-priority patent/WO2002096462A1/en

2003-10-31 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2003-10-31 Publication of IS7012A publication Critical patent/IS7012A/en

Links

ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 title 2
229940122086 Adenosine A2a receptor agonist Drugs 0.000 title 1
229940121948 Muscarinic receptor antagonist Drugs 0.000 title 1
239000002465 adenosine A2a receptor agonist Substances 0.000 title 1
239000000812 cholinergic antagonist Substances 0.000 title 1
229960003920 cocaine Drugs 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
239000000203 mixture Substances 0.000 title 1
230000000414 obstructive effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Emergency Medicine (AREA)

IS7012A 2001-05-25 2003-10-31 Adenosine A2A receptor agonist and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease IS7012A (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US29384201P	2001-05-25	2001-05-25
US29360601P	2001-05-25	2001-05-25
GB0129275A GB0129275D0 (en)	2001-12-06	2001-12-06	Pharmaceutical combination
GB0129396A GB0129396D0 (en)	2001-12-07	2001-12-07	Pharmaceutical combination
GB0210240A GB0210240D0 (en)	2002-05-03	2002-05-03	Pharmaceutical combination
GB0210238A GB0210238D0 (en)	2002-05-03	2002-05-03	Pharmaceutical composition
PCT/EP2002/005725 WO2002096462A1 (en)	2001-05-25	2002-05-24	An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases

Publications (1)

Publication Number	Publication Date
IS7012A true IS7012A (en)	2003-10-31

Family

ID=37667302

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IS7015A IS7015A (en)	2001-05-25	2003-10-31	PDE 4 inhibitor and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease
IS7012A IS7012A (en)	2001-05-25	2003-10-31	Adenosine A2A receptor agonist and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
IS7015A IS7015A (en)	2001-05-25	2003-10-31	PDE 4 inhibitor and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease

Country Status (1)

Country	Link
IS (2)	IS7015A (en)

2003
- 2003-10-31 IS IS7015A patent/IS7015A/en unknown
- 2003-10-31 IS IS7012A patent/IS7012A/en unknown

Also Published As

Publication number	Publication date
IS7015A (en)	2003-10-31

Similar Documents

Publication	Publication Date	Title
EE200300586A (en)	2004-04-15	Combination of adenosine A2A receptor agonist and anticholinergic agent for the treatment of obstructive airways diseases
NO20032277D0 (en)	2003-05-20	Aminothiazoles and their use as adenosine receptor antagonists
IS7801A (en)	2005-04-14	Purine compounds and their use as cannabinoid receptor antagonists
TWI349550B (en)	2011-10-01	A thiazole derivative and adenosine a2a receptor antagonist containing the same
EP1583503A4 (en)	2006-08-09	Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof
NO20011625L (en)	2002-04-25	Foamed well cement compositions with high strength and methods
AU2003273300A1 (en)	2004-03-29	Modified glp-1 receptor agonists and their pharmacological methods of use
DE60110219D1 (en)	2005-05-25	ADENOSINE A2A RECEPTOR ANTAGONISTS
DE60234951D1 (en)	2010-02-11	ADENOSINE A2A RECEPTOR ANTAGONISTS
IL209010A0 (en)	2011-01-31	Use of tnfalpha antibodies and another drug
IL160706A0 (en)	2004-08-31	Peptides acting as both glp-1 receptor agonists and their pharmacological methods of use
IL161572A0 (en)	2004-09-27	Adenosine a2a receptor antagonists
IL163743A0 (en)	2005-12-18	Haloacetamide and azide substituted compounds and methods of use thereof
IL178254A0 (en)	2006-12-31	Receptor coupling agents and therapeutic uses thereof
HUP0401987A3 (en)	2012-12-28	Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
GB0107822D0 (en)	2001-05-23	Sapogenin derivatives their synthesis and use methods based upon their use
AU2002351175A8 (en)	2003-06-10	Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof
NO20043295L (en)	2004-08-06	Solid salt-benzazepine compounds and their use in the preparation of pharmaceutical compounds
IS7012A (en)	2003-10-31	Adenosine A2A receptor agonist and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease
NO20033120L (en)	2003-09-11	2-arylimino-2,3-dihydrotiazole derivatives, processes for their preparation and therapeutic use thereof
NO20030547L (en)	2003-02-04	Azabicyclic derivatives and their therapeutic use
NO20042810L (en)	2004-07-02	Venflaxine hydrochloride monohydrate and processes for its preparation
HUP0402540A3 (en)	2008-04-28	Pharmaceutical combinations of adenosine a-2a and betha-2-adrenergic receptor agonists
NO20042500L (en)	2004-06-15	Chemokine receptor antagonists and methods for their use
IS2487B (en)	2008-12-15	Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof